Pratley_2009_Diabetes.Obes.Metab_11_167

Reference

Title : Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy - Pratley_2009_Diabetes.Obes.Metab_11_167
Author(s) : Pratley RE , Kipnes MS , Fleck PR , Wilson C , Mekki Q
Ref : Diabetes Obes Metab , 11 :167 , 2009
Abstract : Pratley_2009_Diabetes.Obes.Metab_11_167
ESTHER : Pratley_2009_Diabetes.Obes.Metab_11_167
PubMedSearch : Pratley_2009_Diabetes.Obes.Metab_11_167
PubMedID: 19125778

Related information

Citations formats

Pratley RE, Kipnes MS, Fleck PR, Wilson C, Mekki Q (2009)
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy
Diabetes Obes Metab 11 :167

Pratley RE, Kipnes MS, Fleck PR, Wilson C, Mekki Q (2009)
Diabetes Obes Metab 11 :167